Products for Research Use Only
RegisterLogin

CDK12/13-IN-3

CAT: 0013-GTR19259479-01Size: 50 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19259479-01Size:50 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
CDK12/13-IN-3 (Compound 12b) is an orally active CDK inhibitor targeting CDK12 and CDK13, with IC50 values of 107.4 nM and 79.4 nM, respectively. This compound inhibits the phosphorylation of Ser2 on the CTD of RNA polymerase II, induces DNA damage, and downregulates the gene expression involved in the DNA damage response (DDR) . CDK12/13-IN-3 exhibits antiproliferative effects against various cancer cells with nanomolar IC50 values. In mouse models, it demonstrates antitumor activity, favorable pharmacokinetic properties, and an oral bioavailability of 53.6%.
CAS Number
3029608-57-6
Field of Research
Cell Biology, Signal Transduction
Smiles
C (C=C) (=O) N1CC=2C (=C (N=CN2) N3C[C@H] (NC=4N=C (OC) C (Cl) =CN4) CC3) CC1
Molecular Formula
C19H22ClN7O2
Molecular Weight
415.877
Storage Conditions
-20°C
Notes
For research use only.

Related Products

CatalogName
GTR19249505-01CDK12/13-IN-2
GTR19235957-01CDK12/13-IN-1
GTR19239625-01CDK12/13 ligand 1
GTR19184429-01PROTAC CDK12/13 Degrader-1
GTR19203484-01CDK12-IN-3
GTR17896602-01CDK12 Antibody
GTR19188551CDK12-IN-6
GTR19188550-01CDK12-IN-5
GTR18241937-01CDK12 Antibody
GTR17924097-01CDK12 Antibody

Alternative Products

CatalogName
T206377-01CDK12/13-IN-3
HY-160284CDK12/13-IN-1
HY-173042CDK12/13-IN-2
HY-168163CDK12/13 ligand 1
HY-168658CDK12/13 ligand 2
TBI4864-25MGSR-4835, CDK12/13 inhibitor
HY-151110-01PROTAC CDK12/13 Degrader-1
VND18450-01CDK12-IN-3
A23984-10PROTAC CDK12/13 Degrader-1 10mg
A23984-5PROTAC CDK12/13 Degrader-1 5mg

Popular Products